Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD

2 min read
Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD
Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD

Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD

Rochester, NY, July 26, 2023 –HSG Clinical Research, Inc. – the Huntington Study Group’s medical analysis group (CRO) and wholly owned subsidiary (collectively referred to right here as HSG) – has begun offering CRO companies for CHDI Foundation’s Enroll-HD observational examine and medical analysis platform within the USA and Canada.

“CHDI has lengthy supported and labored with the HSG as a medical investigator-facing community of healthcare professionals devoted to Huntington’s illness,” mentioned Robi Blumenstein, President of CHDI Management. “HSG may be very conversant in the HD medical websites all through North America and, with the institution of its medical analysis arm, HSG Clinical Research, it was solely pure that we’d flip to HSG as a CRO for Enroll-HD. HSG brings distinctive area data and continuity to Enroll-HD and the research and trials it helps, and we sit up for the continued enlargement of this relationship over time.”

Enroll-HD is a medical analysis platform and the world’s largest observational examine for Huntington’s illness households that serves as a useful resource for the whole HD neighborhood, together with households, clinicians, researchers, advocates, and the vitally necessary engagement of pharma and biotech corporations creating novel therapeutics. Currently, the Enroll-HD medical database includes greater than 30,000 members from world wide at greater than 155 medical websites in 23 nations.

CHDI and HSG will leverage their experience and innovation to proceed gaining data and perception into the pure historical past of HD, mix their strengths in analysis, medical experience, and examine execution to make sure the continuing success of Enroll-HD, and work collectively to speed up therapeutic growth to make a distinction for these affected by Huntington’s illness.

Shari Kinel, CEO of Huntington Study Group, famous, “CHDI is an unbelievable group and HSG couldn’t be extra excited to work with them on this necessary examine. Our organizations have a shared dedication to bettering the lives of people and households affected by HD, and we’re assured that our joint efforts will result in significant outcomes. We are already trying ahead to future collaboration alternatives.”

Learn extra about Enroll-HD, together with the right way to take part and the way it will help your analysis.

If you’re all in favour of studying extra about alternatives to collaborate with HSG, please contact

About Author